journal article·2025-08Open access

A Multifunctional Nanodelivery System Modified by Fusion Peptides Acts as Teriparatide Carrier for Noise‐Induced Hearing Loss Therapy

Jiawen Li, Zhuowen Hao, Fangzi Ke, Zhihui Liu, Weilong Wang, Sihui Wen, Fan Wu, Bowen Xu, Miao He, Shengyu Zou, Xiong Chen, Jingfeng Li, Zuhong He

Advanced Science· Volume 12· Issue 29

Abstract

Abstract Noise‐induced hearing loss (NIHL) is among the most poorly treated diseases due to irreversible damage to hair cells. Reactive oxygen species contribute to NIHL pathogenesis by injuring the inner ear hair cells. Teriparatide (PTH1‐34) exerts antioxidant properties in the context of osteoporosis. Thus, in the current study, a multifunctional thermosensitive nanodelivery system is developed, based on the unique anatomical structure of the inner ear, to load and sustain the release of PTH1‐34 to alleviate hair cell damage. LR27—a fusion peptide—is assembled from a targeting peptide (A665) and cell‐penetrating peptide (Arg8) to target hair cells and increase the round window membrane permeability. In vitro, the antioxidant and anti‐apoptotic properties of the nanodelivery system are assessed after treating HEI‐OC1 cells and cochlear explants with hydrogen peroxide to simulate the oxidative environment. In vivo, injection of the nanodelivery system into the auditory bulb protects the hearing and hair cells of an NIHL mouse model. These results demonstrate the synergistic effects of multiple peptides in treating NIHL and their potential clinical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hearing, Cochlea, Tinnitus, Genetics · Neuroinflammation and Neurodegeneration Mechanisms · Salivary Gland Disorders and Functions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Otorhinolaryngology‐Head and Neck Surgery Zhongnan Hospital of Wuhan University Wuhan 430071 China

Department of Spine Surgery and Musculoskeletal Tumor Zhongnan Hospital of Wuhan University Wuhan 430071 China

Department of Pathology and Laboratory Medicine the Medical University of South Carolina Charleston 29425 USA

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (49)

Show source-provided references
1. 10.1152/physrev.00053.201710.1152/physrev.00053.2017 ↗
2. 10.1016/j.freeradbiomed.2019.02.02210.1016/j.freeradbiomed.2019.02.022 ↗
3. Ferguson M. A. · Cochrane Database Syst. Rev. · 2017 · 9
4. 10.1371/journal.pone.023242110.1371/journal.pone.0232421 ↗
5. 10.7150/thno.8338310.7150/thno.83383 ↗
6. 10.1186/s12940-020-0566-310.1186/s12940-020-0566-3 ↗
7. 10.1016/j.tins.2019.03.00610.1016/j.tins.2019.03.006 ↗
8. 10.1155/2021/478438510.1155/2021/4784385 ↗
9. 10.1016/j.ecoenv.2022.11399210.1016/j.ecoenv.2022.113992 ↗
10. 10.1016/j.redox.2019.10140610.1016/j.redox.2019.101406 ↗
11. 10.1002/smll.20210659110.1002/smll.202106591 ↗
12. 10.1016/j.apsb.2023.11.00110.1016/j.apsb.2023.11.001 ↗
13. 10.1016/j.jconrel.2023.11.00710.1016/j.jconrel.2023.11.007 ↗
14. 10.1038/s41392-022-00904-410.1038/s41392-022-00904-4 ↗
15. 10.1038/s41573-020-00135-810.1038/s41573-020-00135-8 ↗
16. Silva B. C. · J. Endocrinol. Invest. · 2011 · 34 · 801
17. 10.1016/j.bioactmat.2023.12.01410.1016/j.bioactmat.2023.12.014 ↗
18. 10.1210/endrev/bnab00510.1210/endrev/bnab005 ↗
19. 10.1002/adhm.20230160410.1002/adhm.202301604 ↗
20. 10.1126/scitranslmed.aao093510.1126/scitranslmed.aao0935 ↗
21. 10.1016/j.ijpharm.2015.08.01510.1016/j.ijpharm.2015.08.015 ↗
22. 10.2147/IJN.S15496810.2147/IJN.S154968 ↗
23. 10.1016/j.ijpharm.2011.12.04210.1016/j.ijpharm.2011.12.042 ↗
24. 10.1016/j.biomaterials.2015.09.02510.1016/j.biomaterials.2015.09.025 ↗
25. 10.1016/j.jmrt.2024.04.25310.1016/j.jmrt.2024.04.253 ↗
26. 10.1021/acsnano.3c1104910.1021/acsnano.3c11049 ↗
27. 10.1021/acsnano.3c0886910.1021/acsnano.3c08869 ↗
28. 10.1016/j.jconrel.2018.04.02810.1016/j.jconrel.2018.04.028 ↗
29. 10.1016/j.jconrel.2022.05.05210.1016/j.jconrel.2022.05.052 ↗
30. 10.1016/j.matdes.2023.11256410.1016/j.matdes.2023.112564 ↗
31. 10.1016/j.cej.2023.14658410.1016/j.cej.2023.146584 ↗
32. 10.1038/s41467-023-38597-010.1038/s41467-023-38597-0 ↗
33. 10.3390/pharmaceutics1310165810.3390/pharmaceutics13101658 ↗
34. 10.1126/scitranslmed.aaf436310.1126/scitranslmed.aaf4363 ↗
35. 10.1016/j.redox.2024.10321810.1016/j.redox.2024.103218 ↗
36. 10.1007/s12264-020-00624-110.1007/s12264-020-00624-1 ↗
37. 10.1002/advs.20230521510.1002/advs.202305215 ↗
38. 10.1038/nrm115010.1038/nrm1150 ↗
39. 10.1074/jbc.M31032920010.1074/jbc.M310329200 ↗
40. 10.3390/antiox1110199510.3390/antiox11101995 ↗
41. 10.1038/s41467-019-09566-310.1038/s41467-019-09566-3 ↗
42. 10.7150/thno.5090510.7150/thno.50905 ↗
43. 10.1016/S0378-5955(01)00224-610.1016/S0378-5955(01)00224-6 ↗
44. 10.1007/s00441-015-2113-z10.1007/s00441-015-2113-z ↗
45. 10.1186/s12951-024-02742-810.1186/s12951-024-02742-8 ↗
46. 10.1111/j.1460-9568.2004.03772.x10.1111/j.1460-9568.2004.03772.x ↗
47. 10.1016/j.compbiomed.2023.10698610.1016/j.compbiomed.2023.106986 ↗
48. 10.1038/s41598-017-03773-y10.1038/s41598-017-03773-y ↗
49. 10.1002/advs.20230464110.1002/advs.202304641 ↗